Agoracom: Small Cap Investment - Zenith Epigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

Events

SanFrancisco99

Apr 25, 2017 09:48AM

Re: Events

Nextblockbuster

Apr 25, 2017 10:03AM

Re: Events

fouremm

Apr 25, 2017 10:35AM

Re: Events

KayakerBC

Apr 25, 2017 02:48PM

tada

Rank: President [?]

Points: 7750 [?]

Votes: 40 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Events

in response to

Re: Events

fouremm

posted on Apr 25, 2017 02:57PM

foremm & Nbb - I too have been thinking that there is now a play for ZEN3694. I think they will have to tread a little carefully around the cross pollination as fouremm discibes. Not that it couldn't be done. It just increases the reporting that KD would have to do and if he is going to increase the reporting then why not just increase his position in RVX directly?

It would be nice to get some sort of update on Zenith and where they are at. Isn't it about time for a quarterly update?

tada

3 Recommendations

Re: Events

tada

Apr 25, 2017 03:17PM

Re: Events

KayakerBC

Apr 25, 2017 03:21PM

Re: Events

BearDownAZ

Apr 25, 2017 05:28PM